ALXN 2050, ALXN2050 Placebo Tablets
ALXN2050-NEPH-201
Phase 2 small_molecule active
Quick answer
ALXN 2050, ALXN2050 Placebo Tablets for Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN) is a Phase 2 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active